Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 

Investorideas podcasts on iTunes, Google Play Music and potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts crypto corner    Play by Play – the latest sports headlines and sports stock news


Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

#AI News: EndPoint Technologies and SmartAction Partner to Introduce Call Center Automation to Pharmaceutical and Biotech Industries


MIRAMAR BEACH, Fla. - June 12, 2017 ( Newswire) SmartAction, the leader in artificial intelligence (AI) based solutions for customer self-service, and EndPoint Technologies, a specialty consulting firm focused on Medical Affairs in the life science industry, have formed a strategic partnership to expand the availability and utilization of AI-powered customer self-service technology solutions in the pharmaceutical and biotech industries.

Medical information call centers often provide standardized and structured responses to commonly asked inquiries from health care professionals around the world. Never before have companies considered automating these inquiries, but with SmartAction's powerful AI capabilities, they can. SmartAction's unique solution uses an intelligent virtual agent to handle complex but repeatable customer requests across any medium - voice, SMS text, chat, social media, and mobile. This frees up highly qualified and expert medical information specialists to focus on high value engagements or other intricate inquiries, such as potential Adverse Events or Product Complaints.

"Customer self-service powered by AI is transforming the call center as every day, companies discover they can automate voice and digital conversations they never thought possible," said SmartAction CEO Tom Lewis. "We're excited to have partnered with EndPoint Technologies. They are a crucial partner in educating the pharmaceutical and biotech industries, and ultimately delivering these advanced solutions to them."

Joe Pierce, Founder of EndPoint, stated "EndPoint has extensive experience in medical information solutions and broad relationships in the industry, and SmartAction is the leader in new and innovative technology that will be a part of every medical information call center in the future. This is a partnership that will bring important, innovative technologies to the Medical Affairs industry. EndPoint continually searches for not only new technology solutions to add to our portfolio, but solutions that provide real value and return on investment for our clients. EndPoint is excited to be working with SmartAction to greatly expand the exposure and utilization of this necessary technology."

The medical information industry relies on continuous advancements in call center technology. SmartAction is leading the field with their creation of state-of-the-art AI assisted customer self-service. EndPoint Technologies is the leader in bringing these kinds of tech solutions to the market where their experience and expertise in Medical Affairs information technology gives them intimate knowledge of that industry's unique needs. This timely partnership will create new efficiencies in call center management and radically improve the way Medical Affairs personnel interact with their customers.

About SmartAction:

SmartAction is transforming customer self-service with artificial intelligence. The company works with businesses to create an environment where intelligent virtual agents are handling complex customer requests in every medium - voice, text, chat, social media, and mobile. SmartAction's state-of-the-art technology and industry-leading expertise is fundamentally improving the way customers communicate with the brands they love. SmartAction was recognized by Deloitte as a Tech Fast 500 recipient in 2016. To learn more, visit

About EndPoint Technologies:

EndPoint Technologies is dedicated to providing comprehensive technology and business consulting services to life science organizations. Specializing in Medical Affairs in pharmaceutical and biotech companies, EndPoint provides insight and assistance with the process of selecting and implementing new technology including strategic planning, requirement definition, project management, solutions evaluation, implementation, validation and training. EndPoint also has extensive experience in providing solutions around data privacy, helping companies become and remain compliant. EndPoint also provides systems management, maintenance and support on a number of widely used software solutions. - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS and more

Like Tech Stocks? View our Tech Stocks Directory

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: